🇺🇸 FDA
Pipeline program

Placebo to Match GSK3915393 Tablet

220929

Phase 2 small_molecule active

Quick answer

Placebo to Match GSK3915393 Tablet for Idiopathic Pulmonary Fibrosis is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline Biologicals S.A.
Indication
Idiopathic Pulmonary Fibrosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials